Abstract
Stroke is a significant cause of long-term disability. Currently, once damage from a stroke is established little can be done to recover lost function. Cell transplantation emerged as possible alternative therapy, on the basis of animal studies showing that cells transplanted into the brain not only survive but also lead to functional improvement in different neurodegenerative diseases. Stem cells have been tested in stroke patients as a possible treatment option. While initially stem cells seemed to work by a “cell replacement” mechanism, it is emerging that cell therapy works mostly by providing trophic support to the injured tissue and brain, fostering both neurogenesis and angiogenesis. This review summarizes clinical studies on stem cell transplantation in stroke patients to evaluate the safety, feasibility of administration and tolerability of this experimental treatment. At present there is little evidence to assess the applicability of this treatment in stroke patients and well designed clinical trials are necessary to evaluate safety and toxicity as well as optimal cell type, route and time of delivery.
Keywords: Stem cells, cell transplantation, stroke, cerebrovascular disease, clinical studies, human
Current Vascular Pharmacology
Title: Clinical Studies in Stem Cells Transplantation for Stroke: A Review
Volume: 8 Issue: 1
Author(s): Anna Bersano, Elena Ballabio, Silvia Lanfranconi, Giorgio B. Boncoraglio, Stefania Corti, Federica Locatelli, Pierluigi Baron, Nereo Bresolin, Eugenio Parati and Livia Candelise
Affiliation:
Keywords: Stem cells, cell transplantation, stroke, cerebrovascular disease, clinical studies, human
Abstract: Stroke is a significant cause of long-term disability. Currently, once damage from a stroke is established little can be done to recover lost function. Cell transplantation emerged as possible alternative therapy, on the basis of animal studies showing that cells transplanted into the brain not only survive but also lead to functional improvement in different neurodegenerative diseases. Stem cells have been tested in stroke patients as a possible treatment option. While initially stem cells seemed to work by a “cell replacement” mechanism, it is emerging that cell therapy works mostly by providing trophic support to the injured tissue and brain, fostering both neurogenesis and angiogenesis. This review summarizes clinical studies on stem cell transplantation in stroke patients to evaluate the safety, feasibility of administration and tolerability of this experimental treatment. At present there is little evidence to assess the applicability of this treatment in stroke patients and well designed clinical trials are necessary to evaluate safety and toxicity as well as optimal cell type, route and time of delivery.
Export Options
About this article
Cite this article as:
Bersano Anna, Ballabio Elena, Lanfranconi Silvia, Boncoraglio B. Giorgio, Corti Stefania, Locatelli Federica, Baron Pierluigi, Bresolin Nereo, Parati Eugenio and Candelise Livia, Clinical Studies in Stem Cells Transplantation for Stroke: A Review, Current Vascular Pharmacology 2010; 8 (1) . https://dx.doi.org/10.2174/157016110790226570
DOI https://dx.doi.org/10.2174/157016110790226570 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Potential Novel Benefits of Sodium Restriction in Chronic Kidney Disease
Current Hypertension Reviews Drug release from ordered mesoporous silicas
Current Pharmaceutical Design Carbon Monoxide and the Brain: Time to Rethink the Dogma
Current Pharmaceutical Design Effects of Cholinergic Enhancing Drugs on Cholinergic Transporters in the Brain and Peripheral Blood Lymphocytes of Spontaneously Hypertensive Rats
Current Alzheimer Research Huntingtons Disease: The Value of Transcranial Meganetic Stimulation
Current Medicinal Chemistry Antidiabetics: Structural Diversity of Molecules with a Common Aim
Current Medicinal Chemistry Experimental Study on the High Speed Performance of Bearings
Recent Patents on Mechanical Engineering Micro- and Macrovascular Treatment Targets in Scleroderma Heart Disease
Current Pharmaceutical Design Collagen Receptors as Potential Targets for Novel Anti-Platelet Agents
Current Pharmaceutical Design Molecular Targets and Abdominal Aortic Aneurysms
Recent Patents on Cardiovascular Drug Discovery Homocysteine and Cerebral Ischemia: Pathogenic and Therapeutical Implications
Current Medicinal Chemistry PREFACE
Cardiovascular & Hematological Agents in Medicinal Chemistry Update on Drug Interactions With Phosphodiesterase-5 Inhibitors Prescribed as First-Line Therapy for Patients with Erectile Dysfunction or Pulmonary Hypertension
Current Drug Metabolism Is there U-turn from Insulin Back to Pills in Diabetes?
Current Vascular Pharmacology Understanding the Counterintuitive Phenomenon of Catch Bonds
Current Nanoscience Role of ERK1/2 Activation In Thrombin-Induced Vascular Smooth Muscle Cell Hypertrophy
Current Hypertension Reviews Electron Beam Tomography as a Non Invasive Method to Monitor Effectiveness of Antiatherosclerotic Therapy
Current Drug Targets - Cardiovascular & Hematological Disorders Drug Delivery Systems for the Treatment of Diabetes Mellitus: State of the Art
Current Pharmaceutical Design Blood-Brain Barrier Integrity and Glial Support: Mechanisms that can be Targeted for Novel Therapeutic Approaches in Stroke
Current Pharmaceutical Design Atrial Fibrillation in Acute St-Elevation Myocardial Infarction: Clinical and Prognostic Features
Current Cardiology Reviews